Pale Fire Capital Se A Tyr Pharma Inc Transaction History

Pale Fire Capital Se

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.42 - $2.02 $287,513 - $408,997	-202,474 Reduced 68.94%	91,232 $178 Million
Q4 2023 Feb 13, 2024	BUY	$1.11 - $1.51 $264,012 - $359,151	237,849 Added 425.82%	293,706 $414 Million
Q3 2023 Nov 13, 2023	BUY	$1.55 - $2.23 $86,578 - $124,561	55,857 New	55,857 $88.3 Million

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Pale Fire Capital Se, based on Form 13F filings with the SEC.

Stay updated on Pale Fire Capital Se with notifications on news.